November is dedicated to raising awareness about pancreatic cancer in hopes to shed light on the severity of the disease and advocate for early detection.

Pancreatic cancer is notorious for its high mortality rate. According to recent data, it ranks among the deadliest cancers, with a five-year survival rate of around 10%. Each year thousands are diagnosed, emphasizing the urgent need for awareness and research.

Early detection is challenging, as symptoms often manifest at advanced stages. Warning signs could include abdominal pain, weight loss, jaundice, and digestive issues. Recognizing these symptoms and seeking medical attention promptly is crucial for improving outcomes.

Treatment options vary based on the stage at diagnosis. Surgical resection, chemotherapy, and radiation therapy are common approaches. Research and advancements in immunotherapy offer hope, highlighting the importance of ongoing support for medical research.

GCT is taking an active part in cancer treatment and is an expert in conducting Oncology clinical trials. Please contact us at to learn more about our experience.